Clinical Trials Logo

Phonophobia clinical trials

View clinical trials related to Phonophobia.

Filter by:
  • None
  • Page 1

NCT ID: NCT05207865 Active, not recruiting - Migraine Clinical Trials

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Start date: March 15, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.

NCT ID: NCT00330850 Completed - Migraine Clinical Trials

An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack

Start date: May 2006
Phase: Phase 3
Study type: Interventional

The purpose of the study is to show the efficacy of a single dose of PRO-513 for treating subjects suffering moderate pain form a migraine attack, with or without aura. The study is also intended to show the effectiveness of PRO-513 for associated symptoms of nausea, photophobia, and phonophobia due to a migraine attack.